Based on their new gene expression analysis data, Garvin and colleagues (Garvin et al., 2020) elegantly link the decreased expression of ACE to potential elevation of bradykinin levels and subsequently, to many of COVID‐19 outcomes. This evidence concerns the gene ACE and COVID-19.